參考文獻/References:
[1] 張鶴,白宇寧,劉紹能,等.現(xiàn)代醫(yī)學視角下中醫(yī)“脾主運化”探析[J].北京中醫(yī)藥,2022,41(2):179-181.
[2] MOHAMMADI S,HEDJAZI A,SAJJADIAN M,et al.Accessory spleen in the splenic hilum:a cadaveric study with clinical significance[J].Med Arch,2016,70(5):389-391.
[3] KLOSKA A,WESIERSKA M,MALINOWSKA M,et al.Lipophagy and lipolysis status in lipid storage and lipid metabolism diseases[J].Int J Mol Sci,2020,21(17):6113.
[4] ALMEIDA I,MAGALHÃES S,NUNES A.Lipids:bio-markers of healthy aging[J].Biogerontology,2021,22(3):273-295.
[5] SCHOELER M,CAESAR R.Dietary lipids,gut microbiota and lipid metabolism[J].Rev Endocr Metab Disord,2019,20(4):461-472.
[6] BERMUDEZ-CARDONA J,VELÁSQUEZ-RODRÍGUEZ C.Profile of free fatty acids and fractions of phospholipids,cholesterol esters and triglycerides in serum of obese youth with and without metabolic syndrome[J].Nutrients,2016,8(2):54.
[7] ASAI K,KUZUYA M,NAITO M,et al.Effects of splenectomy on serum lipids and experimental atherosclerosis[J].Angiology,1988,39(6):497-504.
[8] ASAI K,HAYASHI T,KUZUYA M,et al.Delayed clea-rance of beta-very low density lipoprotein after feeding cholesterol to splenectomized rabbits[J].Artery,1990,18(1):32-46.
[9] FATOUROS M,BOURANTAS K,BAIRAKTARI E,et al.Role of the spleen in lipid metabolism[J].Br J Surg,1995,82(12):1675-1677.
[10] 王向東.脾切除對大鼠脂代謝的影響[J].四川醫(yī)學,2015,36(6):825-826.
[11] BAKER K R,MATTHAN N R,LICHTENSTEIN A H,et al.Association of plasma n-6 and n-3 polyunsaturated fatty acids with synovitis in the knee:the MOST study[J].Osteoarthritis Cartilage,2012,20(5):382-387.
[12] LOEF M,IOAN-FACSINAY A,MOOK-KANAMORI D O,et al.The association of plasma fatty acids with hand and knee osteoarthritis:the NEO study[J].Osteoarthritis Cartilage,2020,28(2):223-230.
[13] FREY N,HÜGLE T,JICK S S,et al.Hyperlipidaemia and incident osteoarthritis of the hand:a population-based case-control study[J].Osteoarthritis Cartilage,2017,25(7):1040-1045.
[14] ZHOU M,GUO Y,WANG D,et al.The cross-sectional and longitudinal effect of hyperlipidemia on knee osteoarthritis:results from the Dongfeng-Tongji cohort in China[J].Sci Rep,2017,7(1):9739.
[15] MATHIEU S,COUDERC M,TOURNADRE A,et al.Cardiovascular profile in osteoarthritis:a meta-analysis of cardiovascular events and risk factors[J].Joint Bone Spine,2019,86(6):679-684.
[16] BAUDART P,LOUATI K,MARCELLI C,et al.Association between osteoarthritis and dyslipidaemia:a systematic literature review and meta-analysis[J].RMD Open,2017,3(2):e000442.
[17] FARNAGHI S,CRAWFORD R,XIAO Y,et al.Cholesterol metabolism in pathogenesis of osteoarthritis disease[J].Int J Rheum Dis,2017,20(2):131-140.
[18] POUSINIS P,GOWLER P R W,BURSTON J J,et al.Lipi-domic identification of plasma lipids associated with pain behaviour and pathology in a mouse model of osteoarth-ritis[J].Metabolomics,2020,16(3):32.
[19] IOAN-FACSINAY A,KLOPPENBURG M.Bioactive lipids in osteoarthritis:risk or benefit?[J].Curr Opin Rheumatol,2018,30(1):108-113.
[20] LOEF M,SCHOONES J W,KLOPPENBURG M,et al.Fatty acids and osteoarthritis:different types,different effects[J].Joint Bone Spine,2019,86(4):451-458.
[21] MIAO H,CHEN L,HAO L,et al.Stearic acid induces proinflammatory cytokine production partly through acti-vation of lactate-HIF1α pathway in chondrocytes[J].Sci Rep,2015,5:13092.
[22] AHMAD R,AKHTER N,AL-ROUB A,et al.MIP-1α induction by palmitate in the human monocytic cells implicates TLR4 signaling mechanism[J].Cell Physiol Biochem,2019,52(2):212-224.
[23] MUSTONEN A M,KÄKELÄ R,LEHENKARI P,et al.Distinct fatty acid signatures in infrapatellar fat pad and syno-vial fluid of patients with osteoarthritis versus rheumatoid arthritis[J].Arthritis Res Ther,2019,21(1):124.
[24] MUSTONEN A M,NIEMINEN P.Fatty acids and oxylipins in osteoarthritis and rheumatoid arthritis—a complex field with significant potential for future treatments[J].Curr Rheumatol Rep,2021,23(6):41.
[25] WANG T,HE C.Pro-inflammatory cytokines:the link between obesity and osteoarthritis[J].Cytokine Growth Factor Rev,2018,44:38-50.
[26] LI L,ZHONG S,SHEN X,et al.Recent development on li-quid chromatography-mass spectrometry analysis of oxidized lipids[J].Free Radic Biol Med,2019,144:16-34.
[27] RECCHIUTI A,ISOPI E,ROMANO M,et al.Roles of specialized pro-resolving lipid mediators in autophagy and inflammation[J].Int J Mol Sci,2020,21(18):6637.
[28] KIM A S,CONTE M S.Specialized pro-resolving lipid mediators in cardiovascular disease,diagnosis,and therapy[J].Adv Drug Deliv Rev,2020,159:170-179.
[29] ZAINAL Z,LONGMAN A J,HURST S,et al.Relative efficacies of omega-3 polyunsaturated fatty acids in reducing expression of key proteins in a model system for studying osteoarthritis[J].Osteoarthritis Cartilage,2009,17(7):896-905.
[30] JÓNASDÓTTIR H S,BROUWERS H,KWEKKEBOOM J C,et al.Targeted lipidomics reveals activation of resolution pathways in knee osteoarthritis in humans[J].Osteoarthritis Cartilage,2017,25(7):1150-1160.
[31] HUANG J,BURSTON J J,LI L,et al.Targeting the D series resolvin receptor system for the treatment of osteoarthritis pain[J].Arthritis Rheumatol,2017,69(5):996-1008.
[32] BENABDOUNE H,RONDON E P,SHI Q,et al.The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis[J].Inflamm Res,2016,65(8):635-645.
[33] PAPATHANASIOU I,ANASTASOPOULOU L,TSEZOU A.Cholesterol metabolism related genes in osteoarthritis[J].Bone,2021,152:116076.
[34] GIERMAN L M,KÜHNAST S,KOUDIJS A,et al.Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice—a translational model for atherosclerosis[J].Ann Rheum Dis,2014,73(5):921-927.
[35] DE MUNTER W,VAN DEN BOSCH M H,SLÖETJES A W,et al.High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis[J].Osteoarthritis Cartilage,2016,24(5):844-855.
[36] XU S,TANG C.Cholesterol and hedgehog signaling:mutual regulation and beyond[J].Front Cell Dev Biol,2022,10:774291.
[37] CHOI W S,LEE G,SONG W H,et al.The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis[J].Nature,2019,566(7743):254-258.
[38] ZHANG W,SUN G,AITKEN D,et al.Lysophosphatidylcholines to phosphatidylcholines ratio predicts advanced knee osteoarthritis[J].Rheumatology(Oxford),2016,55(9):1566-1574.
[39] CASTROGIOVANNI P,RAVALLI S,MUSUMECI G.Apoptosis and autophagy in the pathogenesis of osteoarthritis[J].J Invest Surg,2020,33(9):874-875.
[40] HWANG H S,KIM H A.Chondrocyte apoptosis in the pathogenesis of osteoarthritis[J].Int J Mol Sci,2015,16(11):26035-26054.
[41] WANG T,FU X,CHEN Q,et al.Arachidonic acid metabolism and kidney inflammation[J].Int J Mol Sci,2019,20(15):3683.
[42] ZHAI G,PELLETIER J P,LIU M,et al.Activation of the phosphatidylcholine to lysophosphatidylcholine pathway is associated with osteoarthritis knee cartilage volume loss over time[J].Sci Rep,2019,9(1):9648.
[43] RANJPOUR M,WAJID S,JAIN S K.Elevated expression of cytosolic phospholipase a2 delta is associated with lipid metabolism dysregulation during hepatocellular carcinoma progression[J].Cell J,2020,22(1):17-22.
[44] SUN G,BA C L,GAO R,et al.Association of IL-6,IL-8,MMP-13 gene polymorphisms with knee osteoarthritis susceptibility in the Chinese Han population[J].Biosci Rep,2019,39(2):BSR20181346.
[45] 劉天陽,黃傳兵,諶曦,等.“從脾治痹”治療膝骨關節(jié)炎療效觀察[J].遼寧中醫(yī)雜志,2021,48(6):159-162.
[46] 許坤,張潔帆,陳元川,等.退腫通痹湯治療膝骨關節(jié)炎積液性滑膜炎(脾失健運證)的療效觀察[J].中國中醫(yī)骨傷科雜志,2021,29(12):26-31.
相似文獻/References:
[1]孟維娜,明立功,王新德,等.關節(jié)鏡下清理聯(lián)合腓骨近1/3段截骨治療膝骨關節(jié)炎[J].中醫(yī)正骨,2015,27(11):40.
[2]明立功,孟維娜,王新德,等.腓骨近端截骨治療內側間室膝骨關節(jié)炎的近期療效觀察[J].中醫(yī)正骨,2015,27(10):25.
[3]張杰,王人彥,張玉柱.膝骨關節(jié)炎的治療進展[J].中醫(yī)正骨,2015,27(10):68.
[4]梁朝,蔡靜怡,閆立,等.針刀療法改善膝骨關節(jié)炎早期疼痛癥狀的療效評價[J].中醫(yī)正骨,2015,27(09):9.
LIANG Zhao,CAI Jingyi,YAN Li,et al.Evaluation of the curative effect of needle-knife therapy for relieving knee pain in patients with early knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):9.
[5]王建武,黨建軍,李強,等.四聯(lián)療法治療膝骨關節(jié)炎[J].中醫(yī)正骨,2015,27(08):44.
[6]劉紅娟,郭會利,郭樹農.云克聯(lián)合中藥治療膝骨關節(jié)炎的護理[J].中醫(yī)正骨,2015,27(08):75.
[7]陳衛(wèi)衡.探索建立系統(tǒng)的膝骨關節(jié)炎中醫(yī)臨床科研范式
和理論體系[J].中醫(yī)正骨,2015,27(07):1.
[8]鄭春松,葉蕻芝,李西海,等.透骨消痛膠囊中補腎柔肝藥和活血祛風藥治療
骨關節(jié)炎作用方式的計算機模擬比較[J].中醫(yī)正骨,2015,27(07):6.
ZHENG Chunsong,YE Hongzhi,LI Xihai,et al.Comparison of the mode of action of Bushen Rougan(補腎柔肝)drugs versus Huoxue Qufeng(活血祛風)drugs contained in Tougu Xiaotong Jiaonang(透骨消痛膠囊)for the treatment of osteoarthritis:A computer simulation study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):6.
[9]帥波,沈霖,楊艷萍,等.加味青娥丸治療膝骨關節(jié)炎的作用機制研究[J].中醫(yī)正骨,2015,27(07):15.
SHUAI Bo,SHEN Lin,YANG Yanping,et al.Study on the mechanism of action of Jiawei Qing'e Wan(加味青娥丸)for the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):15.
[10]梅其杰,袁長深,段戡,等.壯藥骨痹方燙熨聯(lián)合運動療法治療膝骨關節(jié)炎的臨床研究[J].中醫(yī)正骨,2015,27(07):27.
MEI Qijie,YUAN Changshen,DUAN Kan,et al.Clinical study of the curative effect of hot compressing and rubbing with packet of Gubi Fang(骨痹方)combined with exercise therapy in the treatment of knee osteoarthritis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):27.